RxSight, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $134.5 | $139.9 | $89.1 | $49.0 | $22.6 |
| Operating income | -$48.2 | -$36.9 | -$50.1 | -$63.3 | -$52.8 |
| Net income | -$38.9 | -$27.5 | -$48.6 | -$66.8 | -$48.7 |
| Balance Sheet | |||||
| Total debt | — | — | — | $40.0 | $40.0 |
| Cash Flow Statement | |||||
| Free cash flow | -$19.3 | -$22.4 | -$46.4 | -$61.2 | -$46.6 |
Shares outstanding 41.6M · Free float 76.5%
Annual filing data through FY ended December 31, 2025; float as of October 10, 2026.
Earnings
Other Coverage
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 6, 2026
Small-Cap Signal
Small Caps Leverage Pricing Power Amidst Input Volatility
July 9, 2026
Small-Cap Signal
Agentic AI Drives Explosive Small-Cap Infrastructure Demand